Lucid Diagnostics (LUCD) Return on Sales Growth (3y) (2024 - 2026)

Lucid Diagnostics (LUCD) Return on Sales Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS Growth (3y) (Qtr)
1	Abbott Laboratories	199.63 Bn	194.02 Bn	7.27 Bn	0.00
2	Stryker	127.42 Bn	123.95 Bn	4.50 Bn	0.00
3	Medtronic	118.97 Bn	109.75 Bn	6.41 Bn	0.00
4	Boston Scientific	73.39 Bn	72.85 Bn	3.85 Bn	0.00
5	Edwards Lifesciences	51.97 Bn	47.72 Bn	1.35 Bn	0.00
6	Dexcom	34.32 Bn	32.37 Bn	830.00 Mn	0.00
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	0.00
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	0.00
9	Steris	23.04 Bn	22.56 Bn	684.20 Mn	0.00
10	Lucid Diagnostics	176.73 Mn	143.33 Mn	55,000.00	64.00

Download Data